U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833891) titled 'Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment' on Sept. 16.
Brief Summary: Breast cancer is a heterogeneous disease with multiple molecular subtypes, each requiring tailored therapeutic strategies. The recent introduction of targeted therapies, immunotherapies, and antibody-drug conjugates has expanded treatment options, yet their efficacy varies depending on tumor subtype. This non-interventional study aims to identify novel predictive biomarkers of response or resistance to these emerging therapies. The Senocohort study will prospectively collect clinical, biological, imaging, and organoid-derived...